These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10578256)

  • 21. Characterization and comparison of the lytic function of NKR-P1+ and NKR-P1-rat natural killer cell clones established from NKR-P1bright/TCR alpha beta-cell lines.
    Brissette-Storkus C; Appasamy PM; Hayes LA; Kaufman CL; Ildstad ST; Chambers WH
    Nat Immun; 1995; 14(2):98-113. PubMed ID: 8601077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-evaluation of the involvement of NK cells and C-type lectin-like NK receptors in modulation of immune responses by multivalent GlcNAc-terminated oligosaccharides.
    Grobárová V; Benson V; Rozbeský D; Novák P; Cerný J
    Immunol Lett; 2013; 156(1-2):110-7. PubMed ID: 24076118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of in vivo depletion of NKR-P1+ or CD8+ lymphocytes on the acute rejection of allogeneic lymphocytes (ALC) in the rat.
    Løvik G; Vaage JT; Rolstad B; Naper C
    Scand J Immunol; 2001 Oct; 54(4):341-7. PubMed ID: 11555400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+ T cells.
    Arase N; Arase H; Park SY; Ohno H; Ra C; Saito T
    J Exp Med; 1997 Dec; 186(12):1957-63. PubMed ID: 9396764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delineation of intrathymic T, NK, and dendritic cell (DC) progenitors in fetal and adult rats: demonstration of a bipotent T/DC intermediate precursor.
    Alonso-C LM; Muñoz JJ; Zapata AG
    J Immunol; 2001 Oct; 167(7):3635-41. PubMed ID: 11564776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotype of rat monocytes during acute kidney allograft rejection: increased expression of NKR-P1 and reduction of CD43.
    Scriba A; Grau V; Steiniger B
    Scand J Immunol; 1998 Apr; 47(4):332-42. PubMed ID: 9600314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha/beta-T cell receptor-directed therapy in rat allograft recipients. Long-term survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of Th2-type cytokines.
    Heidecke CD; Hancock WW; Westerholt S; Sewczik T; Jakobs F; Zantl N; Varzaru A; Siegling A; Kurrle R; Deusch K; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(6):948-56. PubMed ID: 8623165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production.
    Beutner U; Launois P; Ohteki T; Louis JA; MacDonald HR
    Eur J Immunol; 1997 Apr; 27(4):928-34. PubMed ID: 9130646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phenotypic and functional analyses of cells infiltrating rat hepatic allograft].
    Osaka Y
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):147-54. PubMed ID: 8464411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function.
    MacDonald HR
    J Exp Med; 1995 Sep; 182(3):633-8. PubMed ID: 7650474
    [No Abstract]   [Full Text] [Related]  

  • 32. CD95L confers immune priviledge to liver grafts which are spontaneously accepted.
    Fändrich F; Lin X; Zhu X; Klöppel G; Parwaresch R; Kremer B
    Transplant Proc; 1998 Jun; 30(4):1057-8. PubMed ID: 9636427
    [No Abstract]   [Full Text] [Related]  

  • 33. Donor liver natural killer cells alleviate liver allograft acute rejection in rats.
    Yu JD; Long TZ; Li GL; Lv LH; Lin HM; Huang YH; Chen YJ; Wan YL
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):386-92. PubMed ID: 21813387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor cell population in the liver allograft reflects the recipient immune status.
    Meyer D; Löffeler S; Otto C; Gassel HJ; Timmermann W; Ulrichs K; Thiede A
    Transplant Proc; 1999; 31(1-2):437. PubMed ID: 10083177
    [No Abstract]   [Full Text] [Related]  

  • 36. Rejection rate of a small bowel allografts is reduced by liver transplantation.
    Meyer D; Gassel HJ; Timmermann W; Otto C; Ulrichs K; Thiede A
    Transplant Proc; 2000 Sep; 32(6):1287. PubMed ID: 10995950
    [No Abstract]   [Full Text] [Related]  

  • 37. Allogeneic heart transplantation activates alloreactive NK cells.
    Petersson E; Ostraat O; Ekberg H; Hansson J; Simanaitis M; Brodin T; Dohlsten M; Hedlund G
    Cell Immunol; 1997 Jan; 175(1):25-32. PubMed ID: 9015185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rejection of spontaneously accepted rat liver allografts with recipientinterleukin-2 treatment or donor irradiation.
    Tu Y; Arima T; Flye MW
    Transplantation; 1997 Jan; 63(2):177-81. PubMed ID: 9020314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of long-term rat renal allograft survival by pretransplant T cell receptor-alpha/beta-targeted therapy.
    Heidecke CD; Zantl N; Maier S; Varzaru A; Hager B; Kupiec-Weglinski J; Hancock WW
    Transplantation; 1996 Jan; 61(2):336-9. PubMed ID: 8600649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.